Cited by 344Diabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and CancerPancreatic function and diabetes

Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.

Open access
Boden, G, Chen, X·1995·Journal of Clinical Investigation

Abstract

It was the aim of this study to determine whether FFA inhibit insulin-stimulated whole body glucose uptake and utilization in patients with non-insulin-dependent diabetes. We performed five types of isoglycemic (approximately 11mM) clamps: (a) with insulin; (b) with insulin plus fat/heparin; (c) with insulin plus glycerol; (d) with saline; (e) with saline plus fat/heparin and two types of euglycemic (approximately 5mM) clamps: (a) with insulin; (b) with insulin plus fat/heparin. During these studies, we determined rates of glucose uptake, glycolysis (both with 3[3H] glucose), glycogen synthesis (determined as glucose uptake minus glycolysis), carbohydrate oxidation (by indirect calorimetry) and nonoxidative glycolysis (determined as glycolysis minus carbohydrate oxidation). Fat/heparin infusion did not affect basal glucose uptake, but inhibited total stimulated (insulin stimulated plus basal) glucose uptake by 40-50% in isoglycemic and in euglycemic patients at plasma FFA concentration of approximately 950 and approximately 550 microM, respectively. In isoglycemic patients, the 40-50% inhibition of total stimulated glucose uptake was due to near complete inhibition of the insulin-stimulated part of glucose uptake. Proportional inhibition of glucose uptake, glycogen synthesis, and glycolysis suggested a major FFA-mediated defect involving glucose transport and/or phosphorylation. In summary, fat produced proportional inhibitions of insulin-stimulated glucose uptake and of intracellular glucose utilization. We conclude, that physiologically elevated levels of FFa could potentially be responsible for a large part of the peripheral insulin resistance in patients with non-insulin-dependent diabetes mellitus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci118160

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both acute (4-hour) and chronic (4-day) physiological elevation of plasma free fatty acid concentration in insulin-sensitive individuals impairs insulin signalling and causes skeletal muscle insulin resistance.

    “Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [68]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Harris, G., G. R. Faloona, and R. H. Unger. 1979. Glucagon. In Methods of Hormone Radioimmunoassay. B. M. Jaff and H. R. Behrmann, editors. Aca- demic Press, Inc., New York, NY. 643-656.
  2. Eggstein, M., and E. Kuhlmann. 1974. Triglyceride and glycerol. Determi- nation after alkaline hydrolysis. In Methods of Enzymatic Analysis. H. U. Berg- meyer, J. Bergmeyer, and M. Grabl, editors. Academic Press, Inc., New York. 1825-1831.

Cited by

Sorted by citations

Authors
Boden, G., & Chen, X.
Affiliations
Temple University (US)
ORCID
Chen, X
Venue
Journal of Clinical Investigation
Published
1995-09-01
Volume
96
Issue
3
Pages
1261-1268
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2115830695
Cited by
344
References
39
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 6 · 2015: 13 · 2014: 8 · 2013: 9 · 2012: 14
FWCI
5.28
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (5r01ag007988-10)
  • National Institute on Aging (R01-AG07988)
  • National Center for Research Resources (M01RR000349, RR-00349)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
free fatty acids, insulin resistance, type 2 diabetes, insulin-stimulated glucose uptake, glucose utilization, glucose transport, glycogen synthesis, glycolysis, carbohydrate oxidation, heparin, fat infusion
MeSH terms
Aged, Analysis of Variance, Blood Glucose, Diabetes Mellitus, Type 2, Emulsions, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Female, Glucagon, Glucose, Heparin, Humans, Infusions, Intravenous, Insulin, Isophane, Male, Middle Aged, Phospholipids, Recombinant Proteins, Safflower Oil, Soybean Oil, Glucose Clamp Technique

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review